BSX vs RMD
Boston Scientific Corp (BSX) and Resmed Inc (RMD) are both filed with the SEC under Surgical & Medical Instruments & Apparatus. BSX is 2.0× RMD's size by market cap ($67.6B against $34.0B); RMD trades at the higher fiscal-year P/E (24.8× against 24.1×); RMD reports the higher net margin (27.2% against 14.4%); BSX grew sales faster over three years (+16.5% against +11.9%); and over the past year RMD returned -12.1% against BSX's -55.7%.
| BSX | RMD | |
|---|---|---|
| Last close | $46.84 | $240.33 |
| Market cap | $67.6B | $34.0B |
| P/E (FY) | 24.1× | 24.8× |
| P/S | 3.4× | 6.6× |
| EV/EBITDA | 15.5× | 17.6× |
| Gross margin | 69.0% | 59.4% |
| Operating margin | 18.0% | 32.7% |
| Net margin | 14.4% | 27.2% |
| Return on equity | 12.6% | 25.9% |
| Sales growth (3y) | +16.5% | +11.9% |
| EPS growth (3y) | +62.8% | +21.5% |
| Dividend yield | 0.0% | 0.9% |
| 1-year return | -55.7% | -12.1% |
Screener snapshot — prices as of 2026-08-28. Each side's last close is the most recent session the snapshot holds for that company, which can be an earlier one, and its 1-year return is measured to that close. Market caps struck on 2026-08-27. Last close, market cap and the 1-year return are price figures; every other row is computed over the company's latest filed fiscal year, and the two differ: BSX FY2025 (ended 2025-12-31); RMD FY2025 (ended 2025-06-30).
Who holds them, and who has traded them
| BSX | RMD | |
|---|---|---|
| Institutional holders (13F) | 1,658 | 933 |
| Insider buyers − sellers (180d) | +3 | -3 |
| Congressional trades disclosed (180d) | 7 | 1 |
| Executive-branch officials on file — trades disclosed (180d) | 18 | 9 |
Counts only. The congressional figures count transactions dated in the trailing 180 days and disclosed in STOCK Act periodic transaction reports; amounts are filed as ranges and are never summed. The executive-branch figures count the same window of transactions, and they are scoped to one roster. The officials OGE posts for direct download. Insider buyers − sellers counts distinct people filing open-market Form 4 purchases minus distinct people filing open-market sales over the trailing 180 days, capped at ±5.
BSX vs RMD: common questions
- Is BSX bigger than RMD?
- BSX carries the larger market cap — $67.6B against $34.0B, both struck on 2026-08-27.
- Which trades at a higher P/E, BSX or RMD?
- RMD, at a fiscal-year 24.8× against 24.1× for BSX. Both are price ÷ latest full-year diluted earnings per share, not a trailing-twelve-month P/E.
- How have BSX and RMD performed over the past year?
- RMD returned -12.1% and BSX -55.7%, measured on the trailing calendar year to the last close.
- How many institutions hold BSX and RMD?
- 1,658 13F filers report a position in BSX and 933 in RMD, on the latest quarter in the panel.
- Are BSX and RMD in the same industry?
- Both are filed with the SEC under Surgical & Medical Instruments & Apparatus, which is the classification this pairing is built on.
BSX overview → · RMD overview → · BSX institutional ownership → · RMD institutional ownership → · Congress and BSX → · Congress and RMD → · Executive branch and BSX → · Executive branch and RMD →
More in Surgical & Medical Instruments & Apparatus: BDX vs BSX · BDX vs DXCM · BDX vs MMM · BDX vs RMD
Stock comparisons lists every pair this site publishes.
Source: SPZCO — https://spzco.com/vs/bsx-vs-rmd